Jianfei Xue

Title: Jianfei Xue: Innovator in Pharmaceutical Technology

Introduction

Jianfei Xue is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the treatment of non-Hodgkin's lymphoma. His innovative approach has led to the development of a unique therapeutic agent that holds promise for patients battling this challenging disease.

Latest Patents

Jianfei Xue holds a patent for the "Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma." This patent discloses a liposomal pharmaceutical preparation of mitoxantrone designed specifically for treating lymphoma. The focus is on non-Hodgkin's lymphoma, especially aggressive forms such as diffuse large B-cell lymphoma and peripheral T-cell lymphoma. The invention emphasizes the use of mitoxantrone liposomes as a standalone anti-tumor therapeutic agent, without the need for combination with other treatments. He has 1 patent to his name.

Career Highlights

Jianfei Xue is associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments that can improve patient outcomes in oncology.

Collaborations

Jianfei collaborates with esteemed colleagues such as Chunlei Li and Yueying Peng. Their combined expertise enhances the innovative potential of their projects and contributes to the advancement of pharmaceutical technologies.

Conclusion

Jianfei Xue's contributions to the field of pharmaceutical technology, particularly through his patent on mitoxantrone liposomes, highlight his role as a key innovator in the treatment of non-Hodgkin's lymphoma. His work continues to inspire advancements in cancer therapy.